Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News PerkinElmer reports continued growth in third quarter of 2017

PerkinElmer reports continued growth in third quarter of 2017

6th November 2017

PerkinElmer has announced its financial results for the third quarter of 2017, during which it delivered a revenue total of $554 million (422.74 million pounds).

This represents a year-on-year increase of eight percent in GAAP terms, or five percent on an organic basis. Both its diagnostics and discovery and analytical solutions divisions experienced strong momentum.

GAAP earnings per share from continuing operations came to $0.87 for the quarter, up from $0.49 in Q3 2016. Operating income, meanwhile, went up from $75.8 million to $79.8 million.

For the full year, the company now forecasts GAAP earnings per share from continuing operations in the range of $2.55 to $2.57.

Robert Friel, chairman and chief executive officer of PerkinElmer, said: "As a result, we remain confident in our improving growth trajectory as these initiatives should enhance our revenue growth in 2018 and beyond."

This follows the recent announcement that the experienced business leader Pascale Witz will be joining the PerkinElmer board of directors.

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.

We have hundreds of jobs available across the Healthcare industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips and straight to your inbox.